Literature DB >> 7842459

Expression of fibronectin during rat fetal and postnatal development: an in situ hybridisation and immunohistochemical study.

J L Samuel1, F Farhadian, A Sabri, F Marotte, V Robert, L Rappaport.   

Abstract

OBJECTIVE: Fibronectin is a protein of the extracellular matrix with numerous binding sites to the other elements of the matrix and to the cells. The aim of this study was to determine the relative importance of fibronectin isoform expression (FN-EIIIA, FN-EIIIB) during fetal and postnatal development of the rat heart.
METHODS: In situ hybridisation and immunolabelling approaches were used to describe the cellular synthesis of fibronectin and its distribution throughout the rat heart from 11 d postconception until adulthood. The distribution of fibronectin was compared to that of laminin and of alpha type III procollagen.
RESULTS: The accumulation and pattern of distribution of the major fibronectin mRNA isoforms were identical, that is, there was a progressive decrease in their accumulation as a function of time after 11 d postconception, resulting in a complete absence in the adult. The distribution of fibronectin and procollagen type III mRNAs were, however, quite distinct. At the protein level the time course of synthesis and secretion of the locally synthesised fibronectin (c-FN) did not follow fibronectin mRNA expression, the accumulation of the protein being rather poor, except just before birth, where it was found mainly in the coronary vessels.
CONCLUSIONS: During the development of the fetal rat heart fibronectin gene transcription is active and progressively decreases with age, whereas the translation of the mRNAs into their corresponding proteins is always relatively poor. If fibronectin is involved in fetal and postnatal morphogenesis of the rat myocardium, it is the plasma form (p-FN) that is most probably involved in the process of growth and differentiation of the rat heart.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7842459     DOI: 10.1093/cvr/28.11.1653

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  8 in total

Review 1.  The extracellular matrix in normal and diseased myocardium.

Authors:  S Hein; J Schaper
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

2.  The contribution of cellular mechanotransduction to cardiomyocyte form and function.

Authors:  Sean P Sheehy; Anna Grosberg; Kevin Kit Parker
Journal:  Biomech Model Mechanobiol       Date:  2012-07-07

Review 3.  Mechanotransduction: the role of mechanical stress, myocyte shape, and cytoskeletal architecture on cardiac function.

Authors:  Megan L McCain; Kevin Kit Parker
Journal:  Pflugers Arch       Date:  2011-04-19       Impact factor: 3.657

Review 4.  Imaging cardiac extracellular matrices: a blueprint for regeneration.

Authors:  Jangwook P Jung; Jayne M Squirrell; Gary E Lyons; Kevin W Eliceiri; Brenda M Ogle
Journal:  Trends Biotechnol       Date:  2011-12-31       Impact factor: 19.536

5.  Spatial and temporal analysis of extracellular matrix proteins in the developing murine heart: a blueprint for regeneration.

Authors:  Kevin P Hanson; Jangwook P Jung; Quyen A Tran; Shao-Pu P Hsu; Rioko Iida; Visar Ajeti; Paul J Campagnola; Kevin W Eliceiri; Jayne M Squirrell; Gary E Lyons; Brenda M Ogle
Journal:  Tissue Eng Part A       Date:  2013-02-14       Impact factor: 3.845

Review 6.  Extracellular matrix and growth factors during heart growth.

Authors:  S Corda; J L Samuel; L Rappaport
Journal:  Heart Fail Rev       Date:  2000-06       Impact factor: 4.214

Review 7.  Engineered Microenvironments for Maturation of Stem Cell Derived Cardiac Myocytes.

Authors:  Rachel R Besser; Matthew Ishahak; Vera Mayo; Daniel Carbonero; Isabella Claure; Ashutosh Agarwal
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

Review 8.  Extracellular Matrix in Regulation of Contractile System in Cardiomyocytes.

Authors:  Natalya Bildyug
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.